Maria C. Freire
Director · BIOGEN INC.
IndividualSelling only
- 2026
- Jun 11, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Maria C. Freire files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Dana Aftab - $7.70M in EXEL purchases and sales in the last 12 months
- Patrick J. Haley - $7.60M in EXEL purchases and sales in the last 12 months
- Julie Smith - $4.69M in EXEL purchases and sales in the last 12 months
- Jack L. Wyszomierski - $4.58M in EXEL purchases and sales in the last 12 months
- Christopher J. Senner - $4.56M in EXEL purchases and sales in the last 12 months
- Stelios Papadopoulos - $4.36M in EXEL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Maria C. Freire?
Maria C. Freire is a corporate insider, tracked as Director of BIOGEN INC. (BIIB). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Maria C. Freire last file a Form 4?
The most recent primary Form 4 on record is dated 11 June 2026, one of 4 filings going back to 2026.
Has Maria C. Freire been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($949K) across all tracked filings.
